Heteropolycyclic compounds and their use as metabotropic...

Details Heteropolycyclic compounds and their use as metabotropic... Heteropolycyclic compounds and their use as metabotropic...

2006-09-26

2006-09-26

Davis, Zinna N. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S269100

Reexamination Certificate

active

07112595

ABSTRACT:
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.

REFERENCES:
patent: 3647809 (1972-03-01), Reiter et al.
patent: 3910940 (1975-10-01), Naranyan
patent: 4003909 (1977-01-01), Narayanan et al.
patent: 4022901 (1977-05-01), Narayanan et al.
patent: 4135910 (1979-01-01), Howe
patent: 5554630 (1996-09-01), Teuber et al.
patent: 5622976 (1997-04-01), Takasugi et al.
patent: 5750470 (1998-05-01), Morimoto et al.
patent: 1 149 011 (1963-05-01), None
patent: 2426878 (1976-01-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO-95/32965 (1995-12-01), None
patent: WO 96/33194 (1996-10-01), None
patent: WO 97/03967 (1997-02-01), None
patent: WO 97/0396706096 (1997-02-01), None
patent: WO 98 17652 (1998-04-01), None
patent: WO 98/57969 (1998-12-01), None
patent: WO 99 02497 (1999-01-01), None
patent: WO 99/26927 (1999-06-01), None
patent: WO 01 12627 (2001-02-01), None
C. Montoliu et al., “Activation of the Metabotropic Glutamate Receptor mGluR5 Prevents Glutamate Toxicity in Primary Cultures of Cerebellar Neurons”, The Journal of Pharmacology and Experimental Therapeutics, May 2, 1997; pp. 643-647; vol. 281; The American Society of Pharmacology and Experimental Therapeutics; USA.
Ksasovitskij et al., Chemical Abstracts, vol. 123, No. 22, Abstract 299726w,608h, p. 447, Nov. 27, 1995.
Yurugi et al., Chemical Pharmaceutical Bulletin, vol. 21, No. 8, pp. 1641-1650, 1973.
William W. Paudler et al., “The Conversion of Imidazo[1,5-a]pyridines into3-(2-Pyridyl)-1,2,4-oxadiazoles”, Conversion of Imadazopyridines into Pyridyloxadiazoles, Aug. 1967, pp. 2430-2433; vol. 32; USA.
T. Ross Kelly et al., “Total Synthesis of Dimethyl Sulfomycinamate”, Tetrahedron Letters, 1995; pp. 5319-5322, vol. 36, No. 30, Elsevier Science Ltd. UK.
Wei Huang et al., “A Novel Improved Procedure for the Synthesis of Oxazoles”, Tetrahedron; 1996; pp. 10131-10136, vol. 52, No. 30; Elsevier Science Ltd., UK.
Mark A. Massa et al., Synthesis of Novel Substituted Pyridines as Inhibitors of Endothelin Converting Enzyme-1 (ECE-1); Bioorganic & Medicinal Chemistry Letters; 1998; pp. 2117-2122, vol. 8, Elsevier Science Ltd., UK.
Luciano Vio et al., “Note-low antihypertensive activity”, Journal; 5807502; EN; 321; 1988; pp. 713-717; Beilstein Instiut zur Foerderung der Chimischen Wissenschaften; Weinheim Germany.
Helene Perrier, et al., “Substituted Furans as Inhibitors of the PDE4 Enzyme”, Biorganic & Medicianl Chemistry Letters; 1999; pp. 323-326, vol. 9, Elsevier Science Ltd. UK.
Edward E. Glover et al. “The Nitration of Imidazo[1,5-a] pyridines” J of the Chem. Soc., Perkins I, 1980, pp. 959-961.
Robert K. Howe et al., “Nitrite Oxide Cycloaddition Routes to 2-(Isoxazolyl)-benzoates and 2-(1,2,4-Oxadiazol-3-yl)benzoates”, J. of Het. Chem., vol. 19, 1982, pp. 721-726.
Beilstein, XFire, CAS Registry No. 65004-22-0, 1988.
S. Robev, Doklady Bolgarskoi Akademil Nauk (1977), 30(7); pp. 1031-1034.

Affiliated with

Also associated with

Rating

Heteropolycyclic compounds and their use as metabotropic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteropolycyclic compounds and their use as metabotropic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteropolycyclic compounds and their use as metabotropic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3599072